Practice-Level Variation in Molecular Testing and Use of Targeted Therapy for Patients With Non–Small Cell Lung Cancer and Colorectal Cancer

IMPORTANCE: All patients with newly diagnosed non–small cell lung cancer (NSCLC) and colorectal cancer (CRC) should receive molecular testing to identify those who can benefit from targeted therapies. However, many patients do not receive recommended testing and targeted therapies. OBJECTIVE: To com...

Descripción completa

Detalles Bibliográficos
Autores principales: Roberts, Thomas J., Kehl, Kenneth L., Brooks, Gabriel A., Sholl, Lynette, Wright, Alexi A., Landrum, Mary Beth, Keating, Nancy L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2023
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10148196/
https://www.ncbi.nlm.nih.gov/pubmed/37115543
http://dx.doi.org/10.1001/jamanetworkopen.2023.10809

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10148196/
https://www.ncbi.nlm.nih.gov/pubmed/37115543
http://dx.doi.org/10.1001/jamanetworkopen.2023.10809

Ejemplares similares